Kat Lange joined Avidity Biosciences in December 2024 and serves as Senior Vice President and Chief Business Officer. Ms. Lange has spent over 15 years in the life sciences and biotechnology industry, with demonstrated leadership and experience in fundraising, strategic advisory, business development and investor relations to help advance novel therapies for the treatment of neuromuscular diseases. Prior to joining Avidity, Ms. Lange served as Chief Financial Officer at Locanabio, leading the finance, investor relations and operations functions. Before Locanabio, she was an executive director in the healthcare investment banking group at J.P. Morgan where she executed more than $18 billion in equity and equity-linked financings and more than $27 billion in various business transactions. She earned a master’s degree in management science from the Judge Business School at Cambridge University and a master’s and bachelor’s degree in natural sciences also from Cambridge University.